Related Experiment Videos
[A clinical trial with ampicillin and sulbactam in various infections]
G Kanra1, G Seçmeer, O F Tarim
1Hacettepe Universitesi, Pediatri Anabilim Dali, Viroloji Unitesi, Ankara.
Abstract:
Eighty four patients with various infections were treated with parenteral ampicillin and sulbactam. Twenty seven patients had meningitis five septic arthritis and osteomyelitis, two systemic salmonellosis, nine intrathoracic infections, five of which were complicated with pleural empyema; thirty patients had infection of the deep tissues of the neck, and the remaining eleven had soft tissue infection in different localizations. The clinical and microbiological results were interpreted together and the overall rate of success in treatment with ampicillin and sulbactam was found to be 98.8%.
Insights
Parenteral ampicillin and sulbactam demonstrated high efficacy in treating diverse infections, achieving a 98.8% success rate. This combination therapy proved effective across various conditions, including meningitis and deep tissue infections.
Area of Science:
- Infectious Diseases
- Pharmacology
- Clinical Medicine
Background:
- Bacterial infections pose significant health challenges requiring effective antimicrobial agents.
- Ampicillin and sulbactam combination offers broad-spectrum activity against various pathogens.
- Assessing treatment outcomes is crucial for optimizing antimicrobial strategies.
Purpose of the Study:
- To evaluate the clinical and microbiological efficacy of parenteral ampicillin and sulbactam in patients with diverse infections.
- To determine the overall success rate of this combination therapy.
Main Methods:
- A cohort of 84 patients with various infections received parenteral ampicillin and sulbactam.
- Infections included meningitis, septic arthritis, osteomyelitis, systemic salmonellosis, intrathoracic infections, deep neck infections, and soft tissue infections.
- Clinical and microbiological outcomes were assessed to determine treatment success.
Main Results:
- The study included 84 patients with a wide range of bacterial infections.
- Ampicillin and sulbactam treatment resulted in an overall success rate of 98.8%.
- The therapy was effective across different infection types, including severe conditions like meningitis and empyema.
Conclusions:
- Parenteral ampicillin and sulbactam is a highly effective treatment for a broad spectrum of bacterial infections.
- The combination therapy demonstrates excellent clinical and microbiological success rates.
- This regimen offers a valuable therapeutic option for managing complex infections.